Dahaghin S, Bierma-Zeinstra SM, Koes BW, Hazes JM, Pols HA, (2007) Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 66: 916-920.
Katz JD, Agrawal S, Velasquez M, (2010) Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome. Curr Opin Rheumatol 22: 512-519.
Pottie P, Presle N, Terlain B, Netter P, Mainard D, et al. (2006) Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis. 65: 1403-1405.
Puenpatom RA, Victor TW, (2009) Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 121: 9-20.
Gomez R, Conde J, Scotece M, Gomez-Reino JJ, Lago F, et al. (2011) What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7: 528-536.
Brennan FM, McInnes IB, (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118: 3537-3545.
Relic B, Zeddou M, Desoroux A, Beguin Y, de Seny D, et al. (2009) Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Lab Invest 89: 811-822.
Conde J, Scotece M, Gomez R, Lopez V, Gomez-Reino JJ, et al. (2011) Adipokines and osteoarthritis: novel molecules involved in the pathogenesis and progression of disease. Arthritis 2011: 203901.
Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, et al. (2006) Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3: e287.
Kushner I, (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 389: 39-48.
Kushner I, Rzewnicki DL, (1994) The acute phase response: general aspects. Baillieres Clin Rheumatol 8: 513-530.
Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR, (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem 280: 2954-2961.
van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC, (2005) Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 280: 35890-35895.
Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, et al. (2010) Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 184: 6427-6437.
Mullan RH, Bresnihan B, Golden-Mason L, Markham T, O'Hara R, et al. (2006) Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum 54: 105-114.
Koga T, Torigoshi T, Motokawa S, Miyashita T, Maeda Y, et al. (2008) Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Lett 582: 579-585.
Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, et al. (2012) Acute-phase serum amyloid A regulates tumor necrosis factor alpha and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy. Arthritis Rheum 64: 1035-1045.
Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T, (2001) The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project. Atherosclerosis 156: 451-456.
Miida T, Yamada T, Seino U, Ito M, Fueki Y, et al. (2006) Serum amyloid A (SAA)-induced remodeling of CSF-HDL. Biochim Biophys Acta 1761: 424-433.
O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B, (2000) Acute-phase serum amyloid A production by rheumatoid arthritis synovial tissue. Arthritis Res 2: 142-144.
O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B, (2004) Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum 50: 1788-1799.
Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, et al. (2000) Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol 27: 58-63.
Vallon R, Freuler F, Desta-Tsedu N, Robeva A, Dawson J, et al. (2001) Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol 166: 2801-2807.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, et al. (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29: 1039-1049.
Arnett FC, Edworthy SM, Bloch DA, MacShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
Kellgren JH, Lawrence JS, (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16: 494-502.
Relic B, Bentires-Alj M, Ribbens C, Franchimont N, Guerne PA, et al. (2002) TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Lab Invest 82: 1661-1672.
Relic B, Benoit V, Franchimont N, Kaiser MJ, Hauzeur JP, et al. (2006) Peroxisome proliferator-activated receptor-gamma1 is dephosphorylated and degraded during BAY 11-7085-induced synovial fibroblast apoptosis. J Biol Chem 281: 22597-22604.
Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, et al. (2010) Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 59: 1648-1656.
Emi N, Friedmann T, Yee JK, (1991) Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 65: 1202-1207.
Benya PD, Padilla SR, Nimni ME, (1978) Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15: 1313-1321.
von der Mark K, Gauss V, von der Mark H, Muller P, (1977) Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 267: 531-532.
Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, et al. (2009) Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 182: 7937-7945.
van den Berg WB, (2011) Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis Cartilage 19: 338-341.
Lee MS, Yoo SA, Cho CS, Suh PG, Kim WU, et al. (2006) Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis. J Immunol 177: 5585-5594.
Mullan RH, McCormick J, Connolly M, Bresnihan B, Veale DJ, et al. (2010) A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A. Am J Pathol 176: 1999-2008.
Baranova IN, Bocharov AV, Vishnyakova TG, Kurlander R, Chen Z, et al. (2010) CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells. J Biol Chem 285: 8492-8506.
Cheng N, He R, Tian J, Ye PP, Ye RD, (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181: 22-26.
Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, et al. (2008) Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol 83: 1174-1180.
Cai H, Song C, Endoh I, Goyette J, Jessup W, et al. (2007) Serum amyloid A induces monocyte tissue factor. J Immunol 178: 1852-1860.
Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N, (2008) Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol 35: 752-756.
Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, et al. (2012) Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 109: 935-940.
Matsunaga N, Tsuchimori N, Matsumoto T, Ii M, (2011) TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol 79: 34-41.
de Seny D, Fillet M, Ribbens C, Maree R, Meuwis MA, et al. (2008) Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem 54: 1066-1075.
Oliviero F, Lo Nigro A, Bernardi D, Giunco S, Baldo G, et al. (2012) A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. Clin Chim Acta 413: 303-307.
Stokes DG, Liu G, Dharmavaram R, Hawkins D, Piera-Velazquez S, et al. (2001) Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors. Biochem J 360: 461-470.
Hayes AJ, Hall A, Brown L, Tubo R, Caterson B, (2007) Macromolecular organization and in vitro growth characteristics of scaffold-free neocartilage grafts. J Histochem Cytochem 55: 853-866.
Fukui N, Ikeda Y, Tanaka N, Wake M, Yamaguchi T, et al. (2011) alphavbeta5 integrin promotes dedifferentiation of monolayer-cultured articular chondrocytes. Arthritis Rheum 63: 1938-1949.
Yoon YM, Kim SJ, Oh CD, Ju JW, Song WK, et al. (2002) Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J Biol Chem 277: 8412-8420.
Thorn CF, Lu ZY, Whitehead AS, (2004) Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol 59: 152-158.
Thorn CF, Whitehead AS, (2002) Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J Immunol 169: 399-406.
Kumon Y, Suehiro T, Faulkes DJ, Hosakawa T, Ikeda Y, et al. (2002) Transcriptional regulation of serum amyloid A1 gene expression in human aortic smooth muscle cells involves CCAAT/enhancer binding proteins (C/EBP) and is distinct from HepG2 cells. Scand J Immunol 56: 504-511.
Ganapathi MK, Rzewnicki D, Samols D, Jiang SL, Kushner I, (1991) Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J Immunol 147: 1261-1265.
Conde J, Gomez R, Bianco G, Scotece M, Lear P, et al. (2011) Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70: 551-559.
Zeddou M, Relic B, Malaise O, Charlier E, Desoroux A, et al. (2012) Differential Signalling Through ALK-1 and ALK-5 Regulates Leptin Expression in Mesenchymal Stem Cells. Stem Cells Dev 21: 1948-1955.
Nair A, Kanda V, Bush-Joseph C, Verma N, Chubinskaya S, et al. (2012) Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis Rheum 64: 2268-2277.
Vlasova MA, Moshkovskii SA, (2006) Molecular interactions of acute phase serum amyloid A: possible involvement in carcinogenesis. Biochemistry (Mosc) 71: 1051-1059.
